Last reviewed · How we verify
Probiotic Agent
A probiotic agent restores beneficial gut microbiota to improve intestinal health and immune function.
A probiotic agent restores beneficial gut microbiota to improve intestinal health and immune function. Used for Microbiota-related disorders (specific indication unknown pending phase 3 data).
At a glance
| Generic name | Probiotic Agent |
|---|---|
| Also known as | Tangwen Tai, BlueBiotics: Ultimate Care, Ecotec, Live Bacillus Licheniformis Cranules, Bifidbacterium |
| Sponsor | Peking Union Medical College Hospital |
| Drug class | Probiotic |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | Phase 3 |
Mechanism of action
Probiotic agents contain live beneficial bacteria that colonize the gastrointestinal tract, promoting a healthy microbiome composition. This can enhance intestinal barrier function, modulate immune responses, and reduce pathogenic bacterial overgrowth. The mechanism supports both local gut health and systemic immune homeostasis.
Approved indications
- Microbiota-related disorders (specific indication unknown pending phase 3 data)
Common side effects
- Gastrointestinal disturbance
- Bloating
- Flatulence
Key clinical trials
- Effect of L. Reuteri LM1063 on Sleep Health Improvement (NA)
- The Effects of a Probiotic Food Supplement in Hyperuricaemia (NA)
- Evaluation of the Ability of Lactobacillus Crispatus CRP21 to Reduce the Incidence of Recurrent Bacterial Vaginosis (NA)
- A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight Individuals (NA)
- Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV Patients (PHASE2)
- Probiotic Improve Constipation (NA)
- Precision Microbiota Interventions for Senoreduction Trial (PHASE1, PHASE2)
- Natural Product System and Lifestyle Modification (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Probiotic Agent CI brief — competitive landscape report
- Probiotic Agent updates RSS · CI watch RSS
- Peking Union Medical College Hospital portfolio CI